Abstract
The response to initial glucocorticoid therapy in childhood acute lymphoblastic leukaemia (ALL) reliably predicts the response to multiagent chemotherapy. Patients resistant to glucocorticoids (prednisone poor responders (PPR)) have a poorer event-free survival compared to glucocorticoid-sensitive patients (prednisone good responders (PGR)). A case–control study was performed to investigate differential protein expression in leukaemic blasts from PGR and PPR childhood ALL patients. Two-dimensional gel electrophoresis (2-DE) was used for an unsupervised screening and surface enhanced laser desorption/ionisation-time of flight mass spectrometry (SELDI-TOF MS) for the characterisation of protein spots. In difference maps of average gels for the proteomes of each responder group, differentially expressed proteins were identified after tryptic digestion and spotting onto H4-SELDI-TOF-MS chips. Proteins overexpressed in PPR were Catalase, RING finger protein 22 alpha, Valosin-containing protein (VCP) and a G-protein-coupled receptor. Proteins overexpressed in PGR were protein kinase C and malate dehydrogenase. Valosin-containing protein was chosen for validation and quantification by Western blot analysis in a second case–control group of ALL patients. In this second independent cohort, median VCP expression (P25–P75) was 0.15 (0.11–0.28) in PGR and 0.34 (0.14–0.99) in PPR patients (P=0.04). We conclude that high VCP expression is associated with poor prednisone response in childhood ALL patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V et al. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 1987; 199: 151–160.
Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122–3133.
Schrappe M, Reiter A, Ludwig W-D, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000; 95: 3310–3322.
Lauten M, Stanulla M, Zimmermann M, Welte K, Riehm H, Schrappe M . Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter. Klin Padiatr 2001; 213: 169–174.
Bahr MJ, Vincent KJ, Arthur MJ, Fowler AV, Smart DE, Wright MC et al. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Hepatology 1999; 29: 839–848.
Dignam JD, Lebovitz RM, Roeder RG . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475–1489.
Blum H, Beier H, Gross HJ . Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987; 8: 93–99.
Kasugai I, Yamada M . High production of catalase in hydrogen peroxide-resistant human leukemia HL-60 cell lines. Leuk Res 1992; 16: 173–179.
Fagioli M, Alcalay M, Tomassoni L, Ferrucci P, Mencarelli A, Riganelli D et al. Cooperation between the RING+B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 1998; 16: 2905–2913.
Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T et al. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J Clin Oncol 2003; 21: 2537–2544.
Senga T, Iwamoto S, Yoshida T, Yokota T, Adachi K, Azuma E et al. LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. Blood 2003; 101: 1185–1187.
Volm M, Zintl F, Edler L, Sauerbrey A . Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1997; 28: 117–126.
Povey S, Jeremiah S, Arthur E, Ber R, Fialkow P, Gardiner E et al. Deficiency of malic enzyme: a possible marker for malignancy in lymphoid cells. Ann Hum Genet 1981; 45 (Part 3): 237–252.
Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa H et al. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 2002; 93: 296–304.
Tsujimoto Y, Tomita Y, Hoshida Y, Kono T, Oka T, Yamamoto S et al. Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res 2004; 10: 3007–3012.
Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Kidogami S, Miyata H et al. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res 2004; 10: 5558–5565.
Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Monden M, Yamamoto S et al. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma. Ann Surg Oncol 2004; 11: 697–704.
Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Nagano H, Dono K et al. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 2003; 21: 447–452.
Yamamoto S, Tomita Y, Hoshida Y, Nagano H, Dono K, Umeshita K et al. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma. Ann Surg Oncol 2004; 11: 165–172.
Yamamoto S, Tomita Y, Hoshida Y, Toyosawa S, Inohara H, Kishino M et al. Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma. Ann Oncol 2004; 15: 1432–1438.
Pui CH, Costlow ME, Kalwinsky DK, Dahl GV . Glucocorticoid receptors in childhood acute non-lymphocytic leukemia. Leuk Res 1983; 7: 11–16.
Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH . Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol 2000; 105: 943–950.
Kaspers GJ, Pieters R, Veerman AJ . Glucocorticoid resistance in childhood leukemia. Int J Pediatr Hematol/Oncol 1997; 4: 583–596.
Shahidi H, Vottero A, Stratakis CA, Taymans SE, Karl M, Longui CA et al. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun 1999; 254: 559–565.
Lauten M, Beger C, Gerdes K, Asgedom G, Kardinal C, Welte K et al. Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia. Leukemia 2003; 17: 1551–1556.
Lauten M, Cario G, Asgedom G, Welte K, Schrappe M . Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. Haematologica 2003; 88: 1253–1258.
Koper JW, Stolk RP, de Lange P, Huizenga NA, Molijn GJ, Pols HA et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet 1997; 99: 663–668.
Anderer G, Schrappe M, Brechlin AM, Lauten M, Muti P, Welte K et al. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics 2000; 10: 715–726.
Lauten M, Matthias T, Stanulla M, Beger C, Welte K, Schrappe M . Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes. Leukemia 2002; 16: 1437–1442.
Dittmar KD, Demady DR, Stancato LF, Krishna P, Pratt WB . Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70. J Biol Chem 1997; 272: 21213–21220.
Kofler R, Schmidt S, Kofler A, Ausserlechner MJ . Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J Endocrinol 2003; 178: 19–27.
Rabilloud T . Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2002; 2: 3–10.
Zhong X, Shen Y, Ballar P, Apostolou A, Agami R, Fang S . AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J Biol Chem 2004; 279: 45676–45684.
Regala R, Weems C, Jamieson L, Copland J, Thompson E, Fields A . Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem 2005; 280: 31109–31115.
Lo A, Liew C, Ngai S, Tsui S, Fung K, Lee C et al. Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1). J Cell Biochem 2005; 94: 763–773.
Song C, Wang Q, Li CC . ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J Biol Chem 2003; 278: 3648–3655.
Yamamoto S, Tomita Y, Hoshida Y, Sakon M, Kameyama M, Imaoka S et al. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Clin Cancer Res 2004; 10: 651–657.
Pleasure IT, Black MM, Keen JH . Valosin-containing protein, VCP, is a ubiquitous clathrin-binding protein. Nature 1993; 365: 459–462.
Cao K, Zheng Y . The Cdc48/p97–Ufd1–Npl4 complex: its potential role in coordinating cellular morphogenesis during the M–G1 transition. Cell Cycle 2004; 3: 422–424.
Ye Y, Meyer HH, Rapoport TA . Function of the p97–Ufd1–Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol 2003; 162: 71–84.
Bachmann PS, Gorman R, Mackenzie KL, Lutze-Mann L, Lock RB . Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor. Blood 2005; 105: 2519–2526.
Tissing WJE, Meijerink JP, den Boer ML, Brinkhof B, Pieters R . mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL. Leukemia 2005; 19: 727–733.
Cario G, Stanulla M, Fine BM, Teuffel O, N VN, Schrauder A et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood 2004; 105: 821–826.
Acknowledgements
We thank Christian Obermaier for his kind and competent support establishing the 2-DE in our laboratory and Girmay Asgedom, Astrid Sundmacher and Silja Roettgers for their excellent technical assistance. This study was supported by the Deutsche Leukämie Forschungshilfe, the Madeleine-Schickedanz-Kinderkrebsstiftung, Erich und Emmy Hoselmann-Stiftung and the Deutsche José Carreras Leukämie-Stiftung (DJCLS R05/16v).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Lauten, M., Schrauder, A., Kardinal, C. et al. Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance. Leukemia 20, 820–826 (2006). https://doi.org/10.1038/sj.leu.2404162
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404162
Keywords
This article is cited by
-
Differential network analysis and protein-protein interaction study reveals active protein modules in glucocorticoid resistance for infant acute lymphoblastic leukemia
Molecular Medicine (2019)
-
Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma
Acta Pharmacologica Sinica (2017)
-
BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia
Blood Cancer Journal (2013)
-
VCP gene variation predicts outcome of advanced non-small-cell lung cancer platinum-based chemotherapy
Tumor Biology (2013)
-
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
Leukemia (2010)